47 records, the earliest from 11 Jun 2016. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.
47 shown.
Sign in to see more, or upgrade your plan to see the full history. Sign in
| Date | Purpose | Notes |
|---|---|---|
| 23 Jul 2026 | Financial Results | Thyrocare Technologies Limited has informed the Exchange about Board Meeting to be held on July 23, 2026 to inter-alia consider and approve the Unaudited Standalone and Consolidated Financial results of the Company for the quarter ended June 30, 2026 |
| 7 May 2026 | Financial Results/Dividend | Thyrocare Technologies Limited has informed the Exchange about Board Meeting to be held on Thursday, May 07, 2026 to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2026, and to recommend the final dividend, if any, for the financial year 2025-26. |
| 28 Jan 2026 | Financial Results | Thyrocare Technologies Limited has informed that the Board Meeting is scheduled to be held on January 28, 2026 to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2025 |
| 14 Oct 2025 | Financial Results/Dividend/Bonus | To consider and approve the Unaudited financial results for quarter and half year ended September 30, 2025, Declaration of an Interim Dividend and Proposal for issue of bonus shares. |
| 23 Jul 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
| 23 Apr 2025 | Financial Results/Dividend | To consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2025, and to recommend the final dividend, if any, for the financial year 2024-25. |
| 23 Jan 2025 | Financial Results | To consider and approve the Unaudited Standalone and Consolidated financial results for the Quarter ended December 31, 2024. |
| 23 Oct 2024 | Financial Results | To consider and approve the financial results for the quarter and half year ended September 30, 2024 |
| 23 Jul 2024 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| 14 May 2024 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024 and recommendation of final dividend, if any |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
